Four IPOs in one night after Dicerna triples on 1st day

Three biotechnology companies went public in a single night on 30 January when Ultragenyx, Trevena and Cara Therapeutics launched initial public offerings and Intra-Cellular Therapies priced an additional IPO to move its stock to the Nasdaq index.